Antonios Douros, MD, Dr

Assistant Professor
Lady Davis Institute

Dr. Douros's research program is in the effectiveness and safety of commonly prescribed medications in vulnerable populations, including patients with liver disease, older adults, as well as patients subjected to polypharmacy and at risk of drug-drug interactions.

Presentation(s):

• SP06A - Comparative Effectiveness and Safety of Apixaban versus Rivaroxaban Among Patients with Non-valvular Atrial Fibrillation and Liver Disease: A Population-based Cohort Study

  Tuesday, August 24, 2021
  3:30 PM – 4:45 PM US Eastern Time

• SP09B - Target Blood Pressure Levels and the Risk of Major Adverse Cardiovascular Events Among Patients with Hypertension at Low Cardiovascular Disease Risk

  Tuesday, August 24, 2021
  5:15 PM – 6:30 PM US Eastern Time

• SP10D - Concomitant Use of Direct Oral Anticoagulants and Antiplatelet Agents and the Risk of Major Bleeding and Death Among Patients with Venous Thromboembolism: Preliminary Results of a Population-based Multinational Cohort Study

  Tuesday, August 24, 2021
  5:15 PM – 6:30 PM US Eastern Time